Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on LinkedIn:
“A special gift arrived today from NEJM: A framed papyrus of the landmark DeLLpi-304 trial sent to the leading author.
Much more than a publication, I hope that tarlatamab and other TCEs will herald a new era that will transform the prognosis of our patients with SCLC/NECs.”
More posts featuring Giannis Mountzios on OncoDaily.